Shockwave Medical Reports Third Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Shockwave Medical (SWAV) PT Raised to $320 at BofA Securities
November 8, 2022 9:17 AM ESTBofA Securities analyst Travis Steed raised the price target on Shockwave Medical (NASDAQ: SWAV) to $320.00 (from $310.00) while maintaining a Buy rating.
"Impressive op margin improvement once again""... MoreShockwave Medical (SWAV) Tops Q3 EPS by 39c, Raises FY Revenue Outlook
November 7, 2022 4:04 PM ESTShockwave Medical (NASDAQ: SWAV) reported Q3 EPS of $0.92, $0.39 better than the analyst estimate of $0.53. Revenue for the quarter came in at $131.3 million versus the consensus estimate of $123.97 million.
GUIDANCE:
Shockwave Medical sees Q4 2022 revenue of $483-488 million, versus the consensus of... More
